All In Biotech

Investigational drug · Phase 3

JX10

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Ischemic Stroke.

Phase 3

Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

1

Any phase or sponsor naming "JX10"

First trial start

2025

May 15, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "JX10", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Acute Ischemic Stroke

Approved drugs for the same conditions: Stroke prevention · Cardiovascular and metabolic

Largest trials

Live from ClinicalTrials.gov: studies naming "JX10" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 7 on PubMed

Also in development for Acute Ischemic Stroke

  • TAK-755rADAMTS13, recombinant ADAMTS13Phase 33 trials

    Takeda · Thrombotic Thrombocytopenic Purpura (TTP), Acute Ischemic Stroke

  • SovateltideIRL-1620, PMZ-1620Phase 32 trials

    Pharmazz, Inc. · Traumatic Brain Injury, Acute Ischemic Stroke, Cerebral Stroke

  • SHPL-49Phase 31 trial

    Shanghai Hutchison Pharmaceuticals Limited · Acute Ischemic Stroke

  • LT3001Phase 23 trials

    Lumosa Therapeutics Co., Ltd. · Acute Ischemic Stroke

  • LT3001 DrugPhase 22 trials

    Shanghai Pharmaceuticals Holding Co., Ltd · Acute Ischemic Stroke

  • B2065Phase 21 trial

    Tasly Pharmaceutical Group Co., Ltd · Acute Ischemic Stroke

  • BB-031DTRI-031Phase 21 trial

    Basking Biosciences, Inc. · Acute Ischemic Stroke

  • HRS-4029Phase 21 trial

    Beijing Suncadia Pharmaceuticals Co., Ltd · Acute Ischemic Stroke

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.